Elsa M. Laughlin

Development and Characterization of Synthetic Glucopyranosyl Lipid Adjuvant System as a Vaccine Adjuvant

Rhea N. Coler, Sylvie Bertholet, Magdalini Moutaftsi et al. · PLoS ONE · 2011 · 311 citations · Full text

Life Sciences, Immunology, Innate Immunity +16

Recurrence of Type 1 Diabetes After Simultaneous Pancreas-Kidney Transplantation, Despite Immunosuppression, Is Associated With Autoantibodies and Pathogenic Autoreactive CD4 T-Cells

Francesco Vendrame, Antonello Pileggi, Elsa M. Laughlin et al. · Diabetes · 2010 · 210 citations · Full text

Life Sciences, Endocrinology, Immunology +17

A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine for use in the prevention of visceral leishmaniasis

Jaya Chakravarty, Subodh Kumar, Sonali Trivedi et al. · Vaccine · 2011 · 170 citations

Veterinary Medicine, Immunology, Infectious Diseases +12

Identification of Human T Cell Antigens for the Development of Vaccines against <i>Mycobacterium tuberculosis</i>

Sylvie Bertholet, Gregory C. Ireton, Maria Kahn et al. · The Journal of Immunology · 2008 · 169 citations · Full text

Life Sciences, Bioinformatics, Immunology +17

GAD65-Specific CD4+ T-Cells with High Antigen Avidity Are Prevalent in Peripheral Blood of Patients With Type 1 Diabetes

Helena Reijonen, Roberto Mallone, Anne‐Kristin Heninger et al. · Diabetes · 2004 · 106 citations · Full text

Life Sciences, Endocrinology, Immunology +17